Based on the analysis of Tourmaline Bio's profitability, liquidity, and operating efficiency, Tourmaline Bio is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March. At this time, Tourmaline Bio's Non Current Assets Total are quite stable compared to the past year. Non Currrent Assets Other is expected to rise to about 1.2 M this year, although the value of Net Debt is projected to rise to (120 M). Key indicators impacting Tourmaline Bio's financial strength include:
The essential information of the day-to-day investment outlook for Tourmaline Bio includes many different criteria found on its balance sheet. An individual investor should monitor Tourmaline Bio's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Tourmaline Bio.
Comparative valuation techniques use various fundamental indicators to help in determining Tourmaline Bio's current stock value. Our valuation model uses many indicators to compare Tourmaline Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tourmaline Bio competition to find correlations between indicators driving Tourmaline Bio's intrinsic value. More Info.
Tourmaline Bio is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . At this time, Tourmaline Bio's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Tourmaline Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Tourmaline Bio Systematic Risk
Tourmaline Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tourmaline Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Tourmaline Bio correlated with the market. If Beta is less than 0 Tourmaline Bio generally moves in the opposite direction as compared to the market. If Tourmaline Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tourmaline Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tourmaline Bio is generally in the same direction as the market. If Beta > 1 Tourmaline Bio moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Tourmaline Bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tourmaline Bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Tourmaline Bio growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Tourmaline Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tourmaline Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tourmaline Bio based on widely used predictive technical indicators. In general, we focus on analyzing Tourmaline Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tourmaline Bio's daily price indicators and compare them against related drivers.
When determining whether Tourmaline Bio is a strong investment it is important to analyze Tourmaline Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tourmaline Bio's future performance. For an informed investment choice regarding Tourmaline Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.49)
Return On Assets
(0.24)
Return On Equity
(0.32)
The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.